AAACTT retweeted
Fantastic 1st @AAACTT_org meeting in @KHCFKHCC in Amman, Jordan.
Outstanding talks with full house and super-delicious “mansaf” @Dr_AmerZeidan (will be jealous)!
Thank you, Chris Kanakry, Ramzi Abboud, Kamil R, @khalahleh1 @ZaidAR_MD @hhashem84 @MKD_BMT @usamagergis @MunaQayed
AAACTT retweeted
Replying to @ASamerAlHomsi1
@ASamerAlHomsi1 president of @AAACTT_org opens the scientific conference and review #GVHD prophylaxis modalities
AAACTT retweeted
The 1st Annual Conference of AAACTT in collaboration with King Hussein Cancer Center is now a reality!
AAACTT retweeted
Outstanding presentation by @usamagergis at the inaugural meeting of #AAACTT in Amman, Jordan on HLA Donor Specific Antibodies @AAACTT_org @ASamerAlHomsi1 @aymansaadOSU @RabiHannaMD @khalahleh1 @Razan_Mohty @MunaQayed @NChokr
AAACTT retweeted
Outstanding presentation by @RabiHannaMD on gene therapy for Thalassemia at the First Annual Conference of #AAACTT in collaboration with the King Hussein Cancer Center in Amman, Jordan @ASamerAlHomsi1 @usamagergis @aymansaadOSU @khalahleh1 @NChokr @Razan_Mohty @AAACTT_org
AAACTT retweeted
CAR T-cell Therapy in Mantle cell with sCNS Involvement.
Active disease PFS only 25%, without active disease about 33%. Perhaps needs post CT maintenance?
@mshadman @gulrayzahmed @awandoc @timfenske @MadihaIqbal13 @MKD_BMT @MCWCancerCenter #lymsm #CART
ashpublications.org/bloodadv…
AAACTT retweeted
Tandem Meetings Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® boothpics.com/ICDB/vlilun
AAACTT retweeted
Congratulations 👏 @DrMonzrAlMalki @AAACTT_org for great presentation at #Tandem24 @ASTCT best abstract
Promising cellular therapy results “Phase 1 study evaluating TSC-100 and TSC-101 in adult leukenia eligible for RIC haploidentical HCT ”. No relapse in 8 patients
AAACTT retweeted
Happy to follow all #Tandem24 updates on twitter. Thank you all ! Missing in person meeting and meeting with friends and colleagues. #attending_on_service
AAACTT retweeted
Congratulations to ASTCT Survivorship SIG Lifetime Achievement Award winner @BipinSavani of @VanderbiltU. 🎉 Thank you for your contributions to the transplantation and cellular therapy field. #Tandem24
AAACTT retweeted
Fascinating “Exploring recent advances in gene therapies in SCD” by @RabiHannaMD
The Gene therapy for Sickle Cell Disease (SCD) has shown promising advancements.
Thank you so much Rabi 👏🏻 – at Al Sharq, Kuwait
AAACTT retweeted
AAACTT annual dinner during The Tandem meetings #TCT24
🗓️Friday 2/23/24
⏲️ 7:00 PM
*Registered members only
AAACTT retweeted
Recommendations for which B-ALL pts to take to allo after CART from @BertainaLab in her wonderful educational talk. What lessons can we apply in the adult setting? Critical and challenging questions here. #bmtsm #leusm #ASH23 @AGomez_MD @Razan_Mohty
AAACTT retweeted
CAST for GVHD Prevention Study bethematch.org/blog/research…
AAACTT retweeted
This abstract relates to the FDA report on T cell lymphoma after CAR-T. Unfortunately it was not selected as an abstract for presentation at the ASH annual meeting and is an "online publication" only. @MoffittNews @MichaelDJain @ASH_hematology
sciencedirect.com/science/ar…
AAACTT retweeted
Fertility Basics for the Peds BMT patients.. chaired by @SethRotz @ThePTCTC @BeTheMatch #HCT. Nice overview of fertility preservation options for our patients prior to #HCT Gene therapy, things we need2 know. Webinar by Dr. Allison Close, see link below bethematch.webex.com/bethema…
AAACTT retweeted
Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML ashpublications.org/blood/ar…
1. 93% CRc after C#2, 79% MRD neg.
2. median fu 15.3: 12-month OS, EFS, and DOR were 82%, 61%, and 65%, respectively
3. 86% received alloHCT
AAACTT retweeted
Hear about Dr. Kharfan-Dabaja's hopeful vision for the future of CAR-T therapy. #InnovationStartsAtMayo
AAACTT retweeted
Meet us in Amman on Nov 16-17 for our first conference on Cell Therapy and Transplantation. Abstract submission and registration open.
AAACTT retweeted
Dr. Kharfan-Dabaja emphasizes the importance of bone marrow transplants in saving lives and promoting hope for patients with blood disorders and cancer, replacing damaged marrow with healthy stem cells. #InnovationStartsAtMayo #BMT
Learn more: mayocl.in/3CrUJdl






































